Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Lipocine Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +4 vs. Q2 2025
- Shares held
- 529.3K
- +852 (+0.2%) vs. Q2 2025
- Total value
- $1.51M
- −$157.7K (−9.4%) vs. Q2 2025
- New holders
- 4
- 4 more added
- Sold out
- 0
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 221,867 | $634.5K | 0.00% | −3,009−1.3% | Reduced |
| BlackRock, Inc. | 89,272 | $254.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 61,076 | $174.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 46,761 | $133.7K | 0.00% | +742+1.6% | Added |
| Renaissance Technologies LLC | 36,097 | $102.9K | 0.00% | +1,300+3.7% | Added |
| State Street Corp | 18,626 | $53.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,247 | $40.7K | 0.00% | +14,247 | New |
| Northern Trust Corp | 13,160 | $37.5K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 12,140 | $34.7K | 0.00% | −11,722−49.1% | Reduced |
| Barclays PLC | 9,412 | $26.8K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,268 | $6.46K | 0.00% | −19−0.8% | Reduced |
| UBS Group AG | 1,766 | $5.03K | 0.00% | +1,291+271.8% | Added |
| Tower Research Capital LLC (TRC) | 1,170 | $3.33K | 0.00% | +497+73.8% | Added |
| Morgan Stanley | 575 | $1.64K | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 471 | $1.34K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 162 | $463 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 67 | $191 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 59 | $169 | 0.00% | +59 | New |
| Tidemark, LLC | 59 | $168 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 49 | $139 | 0.00% | −2,538−98.1% | Reduced |
| Citigroup Inc | 3 | $9 | 0.00% | +3 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |